Cargando…

IgA Deficiency and Nephrotic Syndrome in Children

Background: Imunoglobulin A (IgA) deficiency (IgAD) is the most common form of primary immunodeficiency in Western countries. There have been several reports on IgAD complicated by glomerulonephritis in adults, but only very few cases of IgAD with nephropathy have been reported in children. We prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Genova, Lorenza, Ceppi, Stefania, Stefanelli, Maurizio, Esposito, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121308/
https://www.ncbi.nlm.nih.gov/pubmed/30096909
http://dx.doi.org/10.3390/ijerph15081702
_version_ 1783352437204058112
author Di Genova, Lorenza
Ceppi, Stefania
Stefanelli, Maurizio
Esposito, Susanna
author_facet Di Genova, Lorenza
Ceppi, Stefania
Stefanelli, Maurizio
Esposito, Susanna
author_sort Di Genova, Lorenza
collection PubMed
description Background: Imunoglobulin A (IgA) deficiency (IgAD) is the most common form of primary immunodeficiency in Western countries. There have been several reports on IgAD complicated by glomerulonephritis in adults, but only very few cases of IgAD with nephropathy have been reported in children. We present two cases of IgAD with relapsing nephrotic syndrome in pediatric age. Case presentation: A 4-year-old boy and a 2-year-old boy presented with bilateral periorbital oedema and weight gain. The results of laboratory tests revealed IgAD (IgA < 7 mg/dL), normal creatinine, hypoprotidaemia, hypoalbuminaemia, and nephrotic proteinuria. A diagnosis of IgAD and idiopathic nephrotic syndrome was made, and steroid treatment (prednisone 60 mg/mq/day) was started. During steroid tapering, the children experienced several relapses and to obtain a positive outcome they required therapy with human monoclonal anti-CD20 antibodies (rituximab in the first child, ofatumumab in the second one). Conclusions: Our cases highlight that IgAD can be observed in nephrotic syndrome and nephropathy in children with IgAD appears to be complicated and difficult to treat with corticosteroids alone. Further research is needed to better describe the clinical manifestations and pathological pictures among subjects with IgAD and nephrotic syndrome to understand whether IgAD has a prognostic value in children with nephrotic syndrome and to let clinical physicians define a more personalized and appropriate approach for the management of these patients.
format Online
Article
Text
id pubmed-6121308
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61213082018-09-07 IgA Deficiency and Nephrotic Syndrome in Children Di Genova, Lorenza Ceppi, Stefania Stefanelli, Maurizio Esposito, Susanna Int J Environ Res Public Health Case Report Background: Imunoglobulin A (IgA) deficiency (IgAD) is the most common form of primary immunodeficiency in Western countries. There have been several reports on IgAD complicated by glomerulonephritis in adults, but only very few cases of IgAD with nephropathy have been reported in children. We present two cases of IgAD with relapsing nephrotic syndrome in pediatric age. Case presentation: A 4-year-old boy and a 2-year-old boy presented with bilateral periorbital oedema and weight gain. The results of laboratory tests revealed IgAD (IgA < 7 mg/dL), normal creatinine, hypoprotidaemia, hypoalbuminaemia, and nephrotic proteinuria. A diagnosis of IgAD and idiopathic nephrotic syndrome was made, and steroid treatment (prednisone 60 mg/mq/day) was started. During steroid tapering, the children experienced several relapses and to obtain a positive outcome they required therapy with human monoclonal anti-CD20 antibodies (rituximab in the first child, ofatumumab in the second one). Conclusions: Our cases highlight that IgAD can be observed in nephrotic syndrome and nephropathy in children with IgAD appears to be complicated and difficult to treat with corticosteroids alone. Further research is needed to better describe the clinical manifestations and pathological pictures among subjects with IgAD and nephrotic syndrome to understand whether IgAD has a prognostic value in children with nephrotic syndrome and to let clinical physicians define a more personalized and appropriate approach for the management of these patients. MDPI 2018-08-09 2018-08 /pmc/articles/PMC6121308/ /pubmed/30096909 http://dx.doi.org/10.3390/ijerph15081702 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Di Genova, Lorenza
Ceppi, Stefania
Stefanelli, Maurizio
Esposito, Susanna
IgA Deficiency and Nephrotic Syndrome in Children
title IgA Deficiency and Nephrotic Syndrome in Children
title_full IgA Deficiency and Nephrotic Syndrome in Children
title_fullStr IgA Deficiency and Nephrotic Syndrome in Children
title_full_unstemmed IgA Deficiency and Nephrotic Syndrome in Children
title_short IgA Deficiency and Nephrotic Syndrome in Children
title_sort iga deficiency and nephrotic syndrome in children
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121308/
https://www.ncbi.nlm.nih.gov/pubmed/30096909
http://dx.doi.org/10.3390/ijerph15081702
work_keys_str_mv AT digenovalorenza igadeficiencyandnephroticsyndromeinchildren
AT ceppistefania igadeficiencyandnephroticsyndromeinchildren
AT stefanellimaurizio igadeficiencyandnephroticsyndromeinchildren
AT espositosusanna igadeficiencyandnephroticsyndromeinchildren